Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Details)

v3.21.1
Shareholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended
Oct. 09, 2017
Feb. 25, 2021
Feb. 08, 2021
Jan. 26, 2021
Sep. 30, 2020
Mar. 31, 2021
Dec. 31, 2020
Shareholders' Equity (Details) [Line Items]              
Unregistered shares of common stock       669,980      
Stock consideration (in Dollars)       $ 1,060,150      
Options for purchase           918,000  
Cash payment for warrants (in Dollars)     $ 14,500     $ 14,500  
Warrants for purchase   712,500          
Warrant excercise fee (in Dollars per share)   $ 2.00          
Shares issued           1,007,296  
Purchase agreement (in Dollars)           $ 2,350,000  
Common stock, shares outstanding           17,269,877 14,393,100
Outstanding options intrinsic value (in Dollars)           $ 1,335,934  
Equity-based compensation expense (in Dollars)           $ 2,213,409  
Weighted average fair value (in Dollars per share)           $ 2.41  
Unrecognized compensation expense (in Dollars)           $ 4,116,593  
Weighted average remaining vesting period           1 year 262 days  
Equity Incentive Plan [Member]              
Shareholders' Equity (Details) [Line Items]              
Options for purchase     10,000        
Exercise price (in Dollars per share)     $ 1.45        
Common stock shares available for issuance           139,686  
Option [Member]              
Shareholders' Equity (Details) [Line Items]              
Common stock, shares outstanding           3,437,180  
Consultant [Member]              
Shareholders' Equity (Details) [Line Items]              
Fair value of assumptions, description           This table includes warrants to purchase 91,705 shares of common stock issued to consultants, including the 20,100 issued in the three months ended March 31, 2021, with a total fair value of $140,254 at time of issue, calculated using the Black Scholes model assuming an underlying security values of ranging between $1.30 and $2.03, volatility rate ranging between 103.8% and 109.64%, a risk-free rate of 0.49%, and an expected term of 5.75 years. In the three months ended March 31, 2021, the Company recognized $34,461 in expense associated with these warrants with $53,103 remaining to be recognized.  
Option [Member]              
Shareholders' Equity (Details) [Line Items]              
Shares issued           350,000  
Purchase agreement (in Dollars)           $ 850,900  
Warrant [Member]              
Shareholders' Equity (Details) [Line Items]              
Cash payment for warrants (in Dollars)   $ 1,425,000          
Warrant [Member]              
Shareholders' Equity (Details) [Line Items]              
Cash payment for warrants (in Dollars)           $ 1,425,000  
Warrants for purchase           712,500  
2017 Equity Incentive Plan [Member]              
Shareholders' Equity (Details) [Line Items]              
Common stock issued, shares 1,750,000       5,500,000 1,159,438